6SI1
p53 cancer mutant Y220H
Summary for 6SI1
Entry DOI | 10.2210/pdb6si1/pdb |
Descriptor | Cellular tumor antigen p53, ZINC ION, 1,2-ETHANEDIOL, ... (6 entities in total) |
Functional Keywords | p53, transcription factor, tumor suppressor, cancer therapy, oncogenic mutant, protein misfolding, dna-binding domain, mutant p53 rescue, structural genomics, structural genomics consortium, sgc, dna binding protein |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 2 |
Total formula weight | 49747.01 |
Authors | Joerger, A.C.,Kraemer, A.,Knapp, S.,Structural Genomics Consortium (SGC) (deposition date: 2019-08-08, release date: 2020-02-19, Last modification date: 2024-01-24) |
Primary citation | Bauer, M.R.,Kramer, A.,Settanni, G.,Jones, R.N.,Ni, X.,Khan Tareque, R.,Fersht, A.R.,Spencer, J.,Joerger, A.C. Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm. Acs Chem.Biol., 15:657-668, 2020 Cited by PubMed: 31990523DOI: 10.1021/acschembio.9b00748 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.44 Å) |
Structure validation
Download full validation report